{"id":3446,"date":"2021-09-09T12:05:26","date_gmt":"2021-09-09T03:05:26","guid":{"rendered":"https:\/\/clarivate.com\/ja\/?p=3446"},"modified":"2021-09-09T12:05:26","modified_gmt":"2021-09-09T03:05:26","slug":"six-oncology-breakthroughs-from-mainland-china-takeaways-from-asco-2021-2","status":"publish","type":"post","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/blog\/six-oncology-breakthroughs-from-mainland-china-takeaways-from-asco-2021-2\/","title":{"rendered":"\u4e2d\u56fd\u672c\u571f\u304b\u3089\u306e6\u3064\u306e\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u30fb\u30d6\u30ec\u30a4\u30af\u30b9\u30eb\u30fc: ASCO2021\u3067\u5f97\u3089\u308c\u305f\u3082\u306e"},"content":{"rendered":"<p><a href=\"https:\/\/clarivate.com\/blog\/six-oncology-breakthroughs-from-mainland-china-takeaways-from-asco-2021\/\">\u82f1\u8a9e\u539f\u6587\u30b5\u30a4\u30c8<\/a><\/p>\n<p><span style=\"font-size: small\">\u672c\u8a18\u4e8b\u306f\u82f1\u6587\u30d6\u30ed\u30b0\u3092\u65e5\u672c\u8a9e\u306b\u7ffb\u8a33\u518d\u7de8\u96c6\uff08\u4e00\u90e8\u8ffd\u8a18\u3092\u542b\u3080\uff09\u3057\u305f\u3082\u306e\u3067\u3059\u3002\u672c\u8a18\u4e8b\u306e\u6b63\u5f0f\u8a00\u8a9e\u306f\u82f1\u8a9e\u3067\u3042\u308a\u3001\u305d\u306e\u5185\u5bb9\u30fb\u89e3\u91c8\u306b\u3064\u3044\u3066\u306f\u82f1\u8a9e\u304c\u512a\u5148\u3057\u307e\u3059\u3002<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><em><strong>\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u306e\u304c\u3093\u9818\u57df\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u306f\u3001\u4e2d\u56fd\u672c\u571f\u304b\u3089\u306eASCO 2021\u306e\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u3092\u5206\u6790\u3057\u3001\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u306e\u5c55\u671b\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u3068\u4e88\u60f3\u3055\u308c\u308b\u91cd\u8981\u306a\u30c8\u30ec\u30f3\u30c9\u3068\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u660e\u3089\u304b\u306b\u3057\u307e\u3057\u305f\u3002<\/strong><\/em><\/p>\n<p>&nbsp;<\/p>\n<p>2021\u5e74\u306eASCO\u5e74\u6b21\u7dcf\u4f1a\u3067\u306f\u3001\u4e2d\u56fd\u672c\u571f\u306e\u4f01\u696d\u304c\u5f37\u304f\u6ce8\u76ee\u3055\u308c\u307e\u3057\u305f\u3002\u30c9\u30e9\u30c3\u30b0\u30e9\u30f3\u30c9\u30b9\u30b1\u30fc\u30d7\u306b\u5927\u304d\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u3053\u3068\u304c\u4e88\u60f3\u3055\u308c\u308b\u6cbb\u7642\u6cd5\u306b\u30b9\u30dd\u30c3\u30c8\u3092\u5f53\u3066\u305f<a href=\"https:\/\/clarivate.com\/drugs-to-watch\/\">Drugs to Watch\u2122\u30b7\u30ea\u30fc\u30ba<\/a>\u306e\u4e00\u74b0\u3068\u3057\u3066\u3001\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u306eChina In-Depth\u2122\u306e\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u304c\u4e2d\u56fd\u672c\u571f\u304b\u3089\u306e200\u4ee5\u4e0a\u306e\u6284\u9332\u3092\u30ec\u30d3\u30e5\u30fc\u3057\u3001\u4ee5\u4e0b\u306e\u3088\u3046\u306a\u3044\u304f\u3064\u304b\u306e\u6ce8\u76ee\u3059\u3079\u304d\u30c8\u30ec\u30f3\u30c9\u3092\u78ba\u8a8d\u3057\u307e\u3057\u305f\u3002<\/p>\n<ul>\n<li>\u4e2d\u56fd\u672c\u571f\u306e\u4f01\u696d\u306b\u3088\u308b\u53e3\u982d\u767a\u8868\u306e\u6570\u304c\u3001ASCO 2020\u3067\u306f11\u4ef6\u3060\u3063\u305f\u306e\u306b\u5bfe\u3057\u3001ASCO 2021\u3067\u306f20\u4ef6\u3068\u5927\u5e45\u306b\u5897\u52a0<\/li>\n<li>\u56fa\u5f62\u304c\u3093\u3092\u5bfe\u8c61\u3068\u3057\u305f\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u91cd\u8981\u306a\u81e8\u5e8a\u8a66\u9a13\u3067\u3001\u6709\u671b\u306a\u7d50\u679c\u3092\u767a\u8868\u3059\u308b\u4e2d\u56fd\u4f01\u696d\u306e\u6570\u304c\u5897\u52a0<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>\u56f31\uff1aASCO\u306b\u304a\u3051\u308b\u4e2d\u56fd\u672c\u571f\u304b\u3089\u306e\u53e3\u982d\u767a\u8868\u306e\u6570<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-3447\" src=\"http:\/\/clarivate.com\/life-sciences-healthcare\/wp-content\/uploads\/sites\/4\/2021\/09\/mainland_china_asco_abstracts.png\" alt=\"\" width=\"476\" height=\"294\" srcset=\"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-content\/uploads\/sites\/4\/2021\/09\/mainland_china_asco_abstracts.png 476w, https:\/\/clarivate.com\/life-sciences-healthcare\/wp-content\/uploads\/sites\/4\/2021\/09\/mainland_china_asco_abstracts-300x185.png 300w, https:\/\/clarivate.com\/life-sciences-healthcare\/wp-content\/uploads\/sites\/4\/2021\/09\/mainland_china_asco_abstracts-65x40.png 65w\" sizes=\"auto, (max-width: 476px) 100vw, 476px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-size: small\">\u51fa\u5178: ASCO meeting library<\/span><\/p>\n<p>&nbsp;<\/p>\n<h4>1. \u30a2\u30d9\u30de\u30b7\u30af\u30ea\u30d6\u3001HR\u967d\u6027\/HER2\u9670\u6027\u306e\u30cf\u30a4\u30ea\u30b9\u30af\u65e9\u671f\u4e73\u304c\u3093\u306e\u518d\u767a\u7387\u4f4e\u4e0b\u306b\u52b9\u679c\u3092\u767a\u63ee\u3057\u6ce8\u76ee\u3092\u96c6\u3081\u308b<\/h4>\n<p>&nbsp;<\/p>\n<p>\u30a2\u30d9\u30de\u30b7\u30af\u30ea\u30d6 (\u30a4\u30fc\u30e9\u30a4\u30ea\u30ea\u30fc\u306eVerzenio) \u306f\u3001\u4e2d\u56fd\u672c\u571f\u3067\u306f\u521d\u306eCDK4\/6\u963b\u5bb3\u5264\u3068\u3057\u3066\u3001HR\u967d\u6027\/HER2\u9670\u6027\u306e\u30cf\u30a4\u30ea\u30b9\u30af\u65e9\u671f\u4e73\u304c\u3093\u306b\u5bfe\u3059\u308b\u627f\u8a8d\u3092\u53d6\u5f97\u3059\u308b\u3053\u3068\u306b<sup>1<\/sup><\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u80cc\u666f\uff1a<\/strong>\u4e2d\u56fd\u672c\u571f\u3067\u306f\u73fe\u5728\u3001HR\u967d\u6027\/HER2\u9670\u6027\u306e\u65e9\u671f\u4e73\u304c\u3093\u306e\u518d\u767a\u30ea\u30b9\u30af\u4f4e\u6e1b\u3092\u76ee\u7684\u3068\u3057\u305f\u85ac\u7269\u7642\u6cd5\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u8907\u6570\u306eCDK4\/6\u963b\u5bb3\u5264\u304c\u3001\u3053\u306e\u9ad8\u30ea\u30b9\u30af\u4e73\u304c\u3093\u60a3\u8005\u5c64\u306e\u30a2\u30b8\u30e5\u30d0\u30f3\u30c8\u7642\u6cd5\u3068\u3057\u3066\u8a55\u4fa1\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p><strong>ASCO\u3067\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\uff1a<\/strong>\u30a4\u30fc\u30e9\u30a4\u30ea\u30ea\u30fc\u306f\u3001HR\u967d\u6027\/HER2\u9670\u6027\u306e\u65e9\u671f\u4e73\u304c\u3093\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3001\u30a2\u30d9\u30de\u30b7\u30af\u30ea\u30d6\u3068\u6a19\u6e96\u7684\u306a\u30a2\u30b8\u30e5\u30d0\u30f3\u30c8\u5185\u5206\u6ccc\u7642\u6cd5 (ET) \u3092\u4f75\u7528\u3059\u308b\u5834\u5408\u3068ET\u5358\u72ec\u306e\u5834\u5408\u3092\u6bd4\u8f03\u3059\u308b\u3001\u91cd\u8981\u306a\u7b2c3\u76f8MonarchE\u8a66\u9a13\u306b\u767b\u9332\u3055\u308c\u305f\u4e2d\u56fd\u306e\u60a3\u8005\u96c6\u56e3\u306e\u7d50\u679c\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002CDK4\/6\u963b\u5bb3\u5264\u306f\u3001\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3067\u3042\u308b\u7121\u6d78\u6f64\u751f\u5b58\u671f\u9593\u3060\u3051\u3067\u306a\u304f\u3001\u7121\u9060\u9694\u8ee2\u79fb\u751f\u5b58\u671f\u9593\u306b\u304a\u3044\u3066\u3082\u6709\u52b9\u6027\u3092\u793a\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u4e2d\u56fd\u306e\u60a3\u8005\u306b\u304a\u3051\u308b\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u306f\u3001\u4e16\u754c\u4e2d\u306e\u60a3\u8005\u3067\u89b3\u5bdf\u3055\u308c\u305f\u3082\u306e\u3068\u540c\u69d8\u3067\u3057\u305f\u3002<\/p>\n<p><strong>\u4eca\u5f8c\u306e\u5c55\u671b\uff1a<\/strong>\u4eca\u56de\u306e\u7d50\u679c\u306f\u975e\u5e38\u306b\u6709\u671b\u3067\u3042\u308a\u3001HR\u967d\u6027\/HER2\u9670\u6027\u306e\u9ad8\u30ea\u30b9\u30af\u306e\u65e9\u671f\u4e73\u304c\u3093\u306b\u5bfe\u3059\u308b\u8853\u5f8c\u88dc\u52a9\u7642\u6cd5\u3068\u3057\u3066\u306e\u30a2\u30d9\u30de\u30b7\u30af\u30ea\u30d6\u306e\u9069\u5fdc\u62e1\u5927\u3092\u5f8c\u62bc\u3057\u3059\u308b\u3082\u306e\u3068\u601d\u308f\u308c\u307e\u3059\u3002\u4e2d\u56fd\u672c\u571f\u3067\u306f\u3001\u591a\u304f\u306eCDK4\/6\u963b\u5bb3\u5264 (Jiangsu Hengrui Medicine\u306edalpiciclib\u306a\u3069) \u304c\u958b\u767a\u3055\u308c\u3066\u3044\u307e\u3059\u304c\u3001\u30a2\u30d9\u30de\u30b7\u30af\u30ea\u30d6\u306b\u306f\u9060\u304f\u53ca\u3070\u306a\u3044\u305f\u3081\u3001\u30a4\u30fc\u30e9\u30a4\u30ea\u30ea\u30fc\u306f\u7af6\u4e89\u306e\u6fc0\u3057\u3044\u9818\u57df\u3067\u5927\u304d\u306a\u5148\u884c\u8005\u5229\u76ca\u3092\u5f97\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h4>2. Dalpiciclib\u306f\u3001\u518d\u767a\u8ee2\u79fb\u6027HR\u967d\u6027\/HER2\u9670\u6027\u4e73\u304c\u3093\u5e02\u5834\u306b\u304a\u3044\u3066\u3001\u4ed6\u306eCDK4\/6\u963b\u5bb3\u5264\u3068\u60a3\u8005\u30b7\u30a7\u30a2\u3092\u4e89\u3046\u53ef\u80fd\u6027\u304c\u3042\u308b<\/h4>\n<p>&nbsp;<\/p>\n<p>\u4e2d\u56fd\u306e\u533b\u5e2b\u306f\u3001\u6cbb\u7642\u304c\u56f0\u96e3\u306a\u3053\u306e\u60a3\u8005\u96c6\u56e3\u306b\u5bfe\u3059\u308b\u65b0\u305f\u306a\u6cbb\u7642\u30aa\u30d7\u30b7\u30e7\u30f3\u3092\u6b53\u8fce\u3059\u308b\u3060\u308d\u3046<sup>2<\/sup><\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u80cc\u666f\uff1a<\/strong>2020\u5e7412\u6708\u3001Jiangsu Hengrui Medicine\u306f\u3001\u518d\u767a\u8ee2\u79fb\u6027HR\u967d\u6027\/HER2\u9670\u6027\u4e73\u304c\u3093\u3092\u5bfe\u8c61\u3068\u3057\u305f\u91cd\u8981\u306a\u7b2c3\u76f8\u81e8\u5e8a\u8a66\u9a13 (DAWNA-1) \u306b\u304a\u3044\u3066\u3001dalpiciclib\uff08SHR6390\uff09\u304c\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3092\u9054\u6210\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u3089\u306e\u7d50\u679c\u306b\u57fa\u3065\u304d\u3001Jiangsu Hengrui Medicine\u306f\u3001\u4e2d\u56fd\u672c\u571f\u306b\u304a\u3044\u3066\u3001\u3053\u306e\u6cbb\u7642\u8a2d\u5b9a\u306e\u305f\u3081\u306bdalpiciclib\u3068\u30d5\u30eb\u30d9\u30b9\u30c8\u30e9\u30f3\u30c8\u306e\u4f75\u7528\u7642\u6cd5\u306eNDA\u3092\u7533\u8acb\u3057\u30012021\u5e744\u6708\u306b\u512a\u5148\u5be9\u67fb\u8cc7\u683c\u3092\u5f97\u307e\u3057\u305f\u3002<\/p>\n<p><strong>ASCO\u3067\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\uff1a<\/strong>Jiangsu Hengrui Medicine\u306f\u3001\u30d4\u30dc\u30bf\u30eb\u306a\u7b2c3\u76f8 (DAWNA-1) \u8a66\u9a13\u306e\u7d50\u679c\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002ASCO\u3067\u767a\u8868\u3055\u308c\u305f\u30c7\u30fc\u30bf\u306f\u3001dalpiciclib\u3068\u30d5\u30eb\u30d9\u30b9\u30c8\u30e9\u30f3\u30c8\u306e\u4f75\u7528\u304c\u3001\u30d7\u30e9\u30bb\u30dc\u3068\u30d5\u30eb\u30d9\u30b9\u30c8\u30e9\u30f3\u30c8\u306e\u4f75\u7528\u306b\u6bd4\u3079\u3066\u3001\u3053\u306e\u60a3\u8005\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u7121\u5897\u60aa\u751f\u5b58\u671f\u9593 (PFS) \u3092\u6709\u610f\u306b\u6539\u5584\u3057\u3001\u7ba1\u7406\u53ef\u80fd\u306a\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p><strong>\u4eca\u5f8c\u306e\u5c55\u671b\uff1a<\/strong>\u627f\u8a8d\u3055\u308c\u308c\u3070\u3001dalpiciclib\u306f\u30012018\u5e747\u6708\u306b\u30d5\u30a1\u30a4\u30b6\u30fc\u306e\u30d1\u30eb\u30dc\u30b7\u30af\u30ea\u30d6\u30012021\u5e741\u6708\u306b\u30a4\u30fc\u30e9\u30a4\u30ea\u30ea\u30fc\u306e\u30a2\u30d9\u30de\u30b7\u30af\u30ea\u30d6\u306b\u7d9a\u304d\u3001\u3053\u306e\u60a3\u8005\u5c64\u306b\u5bfe\u3057\u3066NMPA\u3067\u627f\u8a8d\u3055\u308c\u305f3\u3064\u76ee\u306eCDK4\/6\u963b\u5bb3\u5264\u3068\u306a\u308a\u307e\u3059\u3002CDK4\/6\u963b\u5bb3\u5264 (\u30d5\u30eb\u30d9\u30b9\u30c8\u30e9\u30f3\u30c8\u3068\u306e\u4f75\u7528) \u304c\u518d\u767a\u8ee2\u79fb\u6027\u4e73\u304c\u3093\u60a3\u8005\u306e\u75c5\u52e2\u9032\u884c\u3092\u9045\u3089\u305b\u308b\u3068\u3044\u3046\u6709\u610f\u306a\u6539\u5584\u3092\u793a\u3057\u3066\u3044\u308b\u3053\u3068\u3092\u8003\u616e\u3059\u308b\u3068\u3001\u3053\u306e\u85ac\u5264\u30af\u30e9\u30b9\u306f\u3053\u306e\u8a2d\u5b9a\u306b\u304a\u3044\u3066\u597d\u307e\u3057\u3044\u6cbb\u7642\u30aa\u30d7\u30b7\u30e7\u30f3\u3068\u3057\u3066\u3059\u3050\u306b\u6d6e\u4e0a\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h4>3. \u30d4\u30ed\u30c1\u30cb\u30d6\/\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6\u306f\u3001HER2 \u967d\u6027\u4e73\u304c\u3093\u60a3\u8005\u306e\u30cd\u30aa\u30a2\u30b8\u30e5\u30d0\u30f3\u30c8\u7642\u6cd5\u3068\u3057\u3066\u306e\u30da\u30eb\u30c4\u30ba\u30de\u30d6\/\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6\u306e\u5730\u4f4d\u306b\u6311\u6226\u3067\u304d\u308b\u304b\uff1f<\/h4>\n<p>&nbsp;<\/p>\n<p>\u30d4\u30ed\u30c1\u30cb\u30d6 (Aruini) \u306f\u521d\u671f\u306e\u6bb5\u968e\u3067\u6709\u52b9\u6027\u306e\u5146\u5019\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u304c\u3001\u30cd\u30aa\u30a2\u30b8\u30e5\u30d0\u30f3\u30c8\u6cbb\u7642\u306b\u304a\u3051\u308b\u305d\u306e\u5b8c\u5168\u306a\u53ef\u80fd\u6027\u3092\u5206\u6790\u3059\u308b\u306b\u306f\u3001\u3055\u3089\u306b\u591a\u304f\u306e\u30c7\u30fc\u30bf\u304c\u5fc5\u8981<sup>3<\/sup><\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u80cc\u666f\uff1a<\/strong>Jiangsu Hengrui Medicine\u306f\u3001\u4e2d\u56fd\u672c\u571f\u306b\u304a\u3044\u3066\u3001HER2\u967d\u6027\u306e\u65e9\u671f\u4e73\u304c\u3093\u306e\u30a2\u30b8\u30e5\u30d0\u30f3\u30c8\u7642\u6cd5\u3068\u3057\u3066\u3001\u30d4\u30ed\u30c1\u30cb\u30d6 (\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6\u304a\u3088\u3073\u5316\u5b66\u7642\u6cd5\u3068\u306e\u4f75\u7528) \u3092\u691c\u8a0e\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p><strong>ASCO\u3067\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\uff1a<\/strong>Jiangsu Hengrui Medicine\u306f\u3001HER2\u967d\u6027\u306e\u65e9\u671f\u4e73\u304c\u3093\u306e\u30a2\u30b8\u30e5\u30d0\u30f3\u30c8\u7642\u6cd5\u3068\u3057\u3066\u306e\u30d4\u30ed\u30c1\u30cb\u30d6\u306e\u7b2c2\u76f8\u8a66\u9a13\u306e\u7d50\u679c\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u305d\u306e\u7d50\u679c\u3001\u30d4\u30ed\u30c1\u30cb\u30d6\u3092\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6\u3068\u5316\u5b66\u7642\u6cd5\u306b\u4f75\u7528\u3059\u308b\u3053\u3068\u3067\u3001\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6\u3068\u5316\u5b66\u7642\u6cd5\u3092\u4f75\u7528\u3057\u305f\u5834\u5408\u3068\u6bd4\u8f03\u3057\u3066\u3001\u5168\u75c5\u7406\u5b66\u7684\u5b8c\u5168\u594f\u52b9 (tpCR) \u3092\u7d042\u500d\u3068\u5927\u5e45\u306b\u6539\u5584\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u3053\u306e\u60a3\u8005\u96c6\u56e3\u306b\u304a\u3044\u3066\u7ba1\u7406\u53ef\u80fd\u306a\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p><strong>\u4eca\u5f8c\u306e\u5c55\u671b\uff1a<\/strong>\u672c\u5264\u306e\u81e8\u5e8a\u52b9\u679c\u3092\u9069\u5207\u306b\u8a55\u4fa1\u3059\u308b\u305f\u3081\u306b\u306f\u3001\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3067\u3042\u308btpCR\u306b\u52a0\u3048\u3066\u3001\u526f\u6b21\u8a55\u4fa1\u9805\u76ee\u3067\u3042\u308b\u7121\u30a4\u30d9\u30f3\u30c8\u751f\u5b58\u671f\u9593\u3001\u7121\u75c5\u751f\u5b58\u671f\u9593\u3001\u7121\u9060\u9694\u8ee2\u79fb\u751f\u5b58\u671f\u9593\u3001\u5ba2\u89b3\u7684\u594f\u52b9\u7387\u306a\u3069\u306e\u30c7\u30fc\u30bf\u304c\u91cd\u8981\u3068\u306a\u308a\u307e\u3059\u3002\u307e\u305f\u3001\u4e2d\u56fd\u672c\u571f\u306b\u304a\u3044\u3066\u3001\u30d4\u30ed\u30c1\u30cb\u30d6\u3068\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6\u3092\u4f75\u7528\u3057\u305f\u5316\u5b66\u7642\u6cd5\u3068\u3001\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6\u3092\u4f75\u7528\u3057\u305f\u5316\u5b66\u7642\u6cd5\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3092\u8a55\u4fa1\u3059\u308b\u305f\u3081\u306e\u91cd\u8981\u306a\u7b2c3\u76f8\u81e8\u5e8a\u8a66\u9a13\u3092\u5b9f\u65bd\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u8a66\u9a13\u3067\u30d4\u30ed\u30c1\u30cb\u30d6\u3068\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6\u306e\u4f75\u7528\u7642\u6cd5\u306b\u826f\u597d\u306a\u7d50\u679c\u304c\u5f97\u3089\u308c\u308c\u3070\u3001\u30cd\u30aa\u30a2\u30b8\u30e5\u30d0\u30f3\u30c8\u6cbb\u7642\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u306b\u304a\u3044\u3066\u3001\u30da\u30eb\u30c4\u30ba\u30de\u30d6\u3068\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6\u306e\u4f75\u7528\u7642\u6cd5\u306b\u6311\u6226\u3059\u308b\u3053\u3068\u306b\u306a\u308b\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h4>4. Aumolertinib\u304cEGFR\u967d\u6027\u306e\u8ee2\u79fb\u6027NSCLC\u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u6cbb\u7642\u306b\u6709\u52b9\u3067\u3042\u308b\u3053\u3068\u3092\u8a3c\u660e<\/h4>\n<p>&nbsp;<\/p>\n<p>\u30dd\u30b8\u30c6\u30a3\u30d6\u306a\u7b2c3\u76f8\u30c7\u30fc\u30bf\u306b\u3088\u308a\u3001aumolertinib (Ameile) \u306f\u3001\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u306e\u8ee2\u79fb\u6027\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093 (NSCLC) \u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u304a\u3044\u3066\u3001\u552f\u4e00\u306e\u7b2c3\u4e16\u4ee3EGFR\u963b\u5bb3\u5264\u3067\u3042\u308bosimertinib (Tagrisso) \u306e\u7af6\u5408\u85ac\u3068\u3057\u3066\u6d6e\u4e0a\u3059\u308b\u3053\u3068\u306b<sup>4<\/sup><\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u80cc\u666f\uff1a<\/strong>2021\u5e742\u6708\u306b\u767a\u8868\u3055\u308c\u305f\u826f\u597d\u306a\u7b2c3\u76f8\u8a66\u9a13\u7d50\u679c\u306b\u57fa\u3065\u304d\u3001Hansoh Pharma\u306f\u3001\u4e2d\u56fd\u672c\u571f\u306b\u304a\u3051\u308bEGFR\u30a8\u30af\u30bd\u30f319\u6b20\u5931\u307e\u305f\u306fL858R\u5909\u7570\u3092\u6709\u3059\u308b\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u306e\u8ee2\u79fb\u6027\u60a3\u8005\u306e\u6cbb\u7642\u3092\u76ee\u7684\u3068\u3057\u305f\u9769\u65b0\u7684\u306a\u7b2c3\u4e16\u4ee3EGFR\u963b\u5bb3\u5264\u30aa\u30a6\u30e0\u30bb\u30eb\u30c1\u30cb\u30d6\u306b\u3064\u3044\u3066\u30012021\u5e744\u6708\u306b\u753b\u671f\u7684\u6cbb\u7642\u85ac\u306e\u6307\u5b9a\u3092\u53d7\u3051\u30012021\u5e745\u6708\u306b\u512a\u5148\u5be9\u67fb\u8cc7\u683c\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u3002<\/p>\n<p><strong>ASCO\u3067\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\uff1a<\/strong>\u91cd\u8981\u306a\u7b2c3\u76f8\u81e8\u5e8a\u8a66\u9a13\u306e\u7d50\u679c\u3001\u30aa\u30e2\u30e9\u30ea\u30c6\u30a3\u30cb\u30d6\u306f\u30b2\u30d5\u30a3\u30c1\u30cb\u30d6\u3068\u6bd4\u8f03\u3057\u3066PFS\u3068\u594f\u52b9\u671f\u9593 (DoR) \u3092\u6709\u610f\u306b\u5ef6\u9577\u3057\u3001\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3082\u826f\u597d\u3067\u3042\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n<p><strong>\u4eca\u5f8c\u306e\u5c55\u671b\uff1a<\/strong>aumolertinib\u304c\u627f\u8a8d\u3055\u308c\u308c\u3070\u3001\u4e2d\u56fd\u672c\u571f\u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u306e\u8ee2\u79fb\u6027NSCLC\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u304a\u3044\u3066\u30012019\u5e749\u6708\u306eTagrisso\u306e\u627f\u8a8d\u306b\u7d9a\u304d\u30012\u3064\u76ee\u306e\u9769\u65b0\u7684\u306a\u7b2c3\u4e16\u4ee3EGFR\u963b\u5bb3\u5264\u3068\u306a\u308a\u307e\u3059\u3002Aumolertinib\u304c\u627f\u8a8d\u3055\u308c\u308c\u3070\u3001\u4e2d\u56fd\u3067\u306e\u7b2c3\u4e16\u4ee3EGFR\u963b\u5bb3\u5264\u306e\u4f7f\u7528\u304c\u3055\u3089\u306b\u4fc3\u9032\u3055\u308c\u307e\u3059\u304c\u3001Tagrisso\u306e\u5e02\u5834\u521d\u306e\u512a\u4f4d\u6027\u3001\u9ad8\u3044\u5024\u3054\u308d\u611f\u3001\u304a\u3088\u3073\u305d\u306e\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u306e\u5165\u624b\u53ef\u80fd\u6027\u306b\u3088\u308a\u3001\u3053\u306e\u6cbb\u7642\u6cd5\u306b\u304a\u3051\u308bAumolertinib\u306e\u53d6\u308a\u8fbc\u307f\u306f\u5236\u9650\u3055\u308c\u308b\u3067\u3057\u3087\u3046\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h4>5. \u9032\u884c\u6027\u809d\u7d30\u80de\u304c\u3093\u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u306b\u304a\u3051\u308b\u30c9\u30ca\u30d5\u30a7\u30cb\u30d6\u306e\u30bd\u30ec\u30d5\u30cb\u30d6 (\u30cd\u30af\u30b5\u30d0\u30fc\u30eb) \u306b\u5bfe\u3059\u308b\u512a\u4f4d\u6027\u3092\u793a\u3059<\/h4>\n<p>&nbsp;<\/p>\n<p>\u30c9\u30ca\u30d5\u30a7\u30cb\u30d6\u304c\u9032\u884c\u6027\u809d\u7d30\u80de\u304c\u3093 (HCC) \u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u3068\u3057\u3066\u63a1\u7528\u3055\u308c\u308b\u306b\u306f\u3001\u30dd\u30b8\u30c6\u30a3\u30d6\u306a\u30d5\u30a7\u30fc\u30baIII\u30c7\u30fc\u30bf\u304c\u3042\u308c\u3070\u5341\u5206\u304b\uff1f<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u80cc\u666f\uff1a<\/strong>\u30bd\u30e9\u30d5\u30a7\u30cb\u30d6\u306f\u3001\u9032\u884c\u671f\u809d\u7d30\u80de\u304c\u3093\u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u3068\u3057\u3066\u3001\u4e16\u754c\u4e2d\u3067\u9577\u3044\u9593\u3001\u4ed6\u306e\u8ffd\u968f\u3092\u8a31\u3055\u306a\u3044\u6a19\u6e96\u6cbb\u7642\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u30bd\u30e9\u30d5\u30a7\u30cb\u30d6\u306b\u3088\u308b\u5168\u751f\u5b58\u671f\u9593 (OS) \u306e\u5ef6\u9577\u306f\u308f\u305a\u304b\u3067\u3042\u308a\u3001\u91cd\u7be4\u306a\u6709\u5bb3\u4e8b\u8c61\u3092\u4f34\u3044\u307e\u3059\u3002\u30ec\u30f3\u30d0\u30c1\u30cb\u30d6\u3092\u8a55\u4fa1\u3057\u305f\u7b2c3\u76f8\u8a66\u9a13 (REFLECT) \u3067\u3082\u3001\u30bd\u30e9\u30d5\u30a7\u30cb\u30d6\u3068\u6bd4\u8f03\u3057\u3066\u7d71\u8a08\u7684\u306b\u6709\u610f\u306aOS\u306e\u6539\u5584\u3092\u793a\u3059\u3053\u3068\u304c\u3067\u304d\u307e\u305b\u3093\u3067\u3057\u305f\u3002\u305d\u306e\u305f\u3081\u3001\u3053\u306e\u60a3\u8005\u306b\u306f\u3001\u65e2\u5b58\u306e\u6cbb\u7642\u6cd5\u3088\u308a\u3082\u5168\u751f\u5b58\u671f\u9593\u306e\u5ef6\u9577\u3068\u5b89\u5168\u6027\u306e\u5411\u4e0a\u3092\u3082\u305f\u3089\u3059\u85ac\u5264\u304c\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u3068\u3057\u3066\u6b8b\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p><strong>ASCO\u3067\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\uff1a<\/strong>Zelgen Biopharmaceuticals\u306f\u3001\u9032\u884c\u6027\u809d\u7d30\u80de\u304c\u3093\u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u6cbb\u7642\u306b\u304a\u3044\u3066\u3001\u30c9\u30ca\u30d5\u30a7\u30cb\u30d6\u3068\u30bd\u30e9\u30d5\u30a7\u30cb\u30d6\u3092\u6bd4\u8f03\u3057\u305f\u3001\u30d8\u30c3\u30c9\u30c4\u30fc\u30d8\u30c3\u30c9\u306e\u30d4\u30dc\u30bf\u30eb\u7b2c3\u76f8\u8a66\u9a13\u306e\u7d50\u679c\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u305d\u306e\u7d50\u679c\u3001\u30c9\u30ca\u30d5\u30a7\u30cb\u30d6\u306f\u30bd\u30e9\u30d5\u30a7\u30cb\u30d6\u3088\u308a\u3082\u60a3\u8005\u306eOS\u3092\u6709\u610f\u306b\u6539\u5584\u3057\u3001\u5b89\u5168\u6027\u3068\u5fcd\u5bb9\u6027\u306e\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3082\u826f\u597d\u3067\u3042\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n<p><strong>\u4eca\u5f8c\u306e\u5c55\u671b\uff1a<\/strong>\u30c9\u30ca\u30d5\u30a7\u30cb\u30d6\u304c\u30bd\u30e9\u30d5\u30a7\u30cb\u30d6\u3088\u308a\u3082\u751f\u5b58\u671f\u9593\u3092\u5ef6\u9577\u3057\u305f\u3053\u3068\u306f\u5fc3\u5f37\u3044\u3053\u3068\u3067\u3059\u304c\u3001\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u5264\u3068TKI\u3001VEGF\u963b\u5bb3\u5264\u3001CTLA-4\u963b\u5bb3\u5264\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u4f75\u7528\u7642\u6cd5\u306e\u767b\u5834\u306b\u3088\u308a\u3001\u305d\u306e\u52b9\u679c\u306f\u5f71\u3092\u6f5c\u3081\u308b\u3053\u3068\u304c\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306a\u4f75\u7528\u7642\u6cd5\u306f\u3001\u8907\u6570\u306e\u88fd\u85ac\u30e1\u30fc\u30ab\u30fc\u304c\u4e2d\u56fd\u306e\u809d\u7d30\u80de\u304c\u3093\u5e02\u5834\u5411\u3051\u306b\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u6cbb\u7642\u6cd5\u306e\u591a\u304f\u306f\u3001\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u306e\u9032\u884c\u3057\u305f\u809d\u7d30\u80de\u304c\u3093\u3092\u5bfe\u8c61\u3068\u3057\u305f\u5f8c\u671f\u81e8\u5e8a\u8a66\u9a13\u3067\u691c\u8a0e\u3055\u308c\u3066\u304a\u308a\u3001\u3053\u306e\u3088\u3046\u306a\u6cbb\u7642\u74b0\u5883\u3067\u306fTKI\u5358\u72ec\u3088\u308a\u3082\u512a\u308c\u305f\u6709\u52b9\u6027\u3068\u5fcd\u5bb9\u6027\u304c\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30c9\u30cd\u30d5\u30a7\u30cb\u30d6\u304c\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u6cbb\u7642\u3067\u5e02\u5834\u3092\u5927\u304d\u304f\u62e1\u5927\u3059\u308b\u898b\u8fbc\u307f\u306f\u3001\u30bd\u30e9\u30d5\u30a7\u30cb\u30d6\u304c\u5e02\u5834\u3067\u9577\u304f\u5b58\u5728\u3057\u3066\u3044\u308b\u305f\u3081\u3001\u533b\u5e2b\u306e\u5b89\u5fc3\u611f\u304c\u9ad8\u304f\u3001\u4fa1\u683c\u3082\u624b\u9803\u3067\u3001\u8cbb\u7528\u5bfe\u52b9\u679c\u306e\u9ad8\u3044\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u304c\u5165\u624b\u53ef\u80fd\u3067\u3042\u308b\u3053\u3068\u3082\u554f\u984c\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h4>6. \u30c8\u30ea\u30d1\u30ea\u30de\u30d6\u304c\u518d\u767a\u30fb\u8ee2\u79fb\u6027\u4e0a\u54bd\u982d\u304c\u3093\u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3068\u3057\u3066\u6709\u671b<\/h4>\n<p>&nbsp;<\/p>\n<p>\u826f\u597d\u306a\u7d50\u679c\u306f\u3001\u30c8\u30ea\u30d1\u30ea\u30de\u30d6 (Junshi Biosciences\u306eTuoyi) \u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u306e\u8ee2\u79fb\u6027\u4e0a\u54bd\u982d\u304c\u3093 (NPC) \u60a3\u8005\u96c6\u56e3\u306b\u304a\u3051\u308b\u9069\u5fdc\u62e1\u5927\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3001\u4e2d\u56fd\u672c\u571f\u306ePD-1\u963b\u5bb3\u5264\u5e02\u5834\u306b\u304a\u3051\u308b\u56fd\u5185\u30e1\u30fc\u30ab\u30fc\u306e\u512a\u4f4d\u6027\u3092\u3055\u3089\u306b\u5f37\u56fa\u306a\u3082\u306e\u306b6<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u80cc\u666f\uff1a<\/strong>2021\u5e742\u6708\u3001Junshi Biosciences\u306f\u3001\u524d\u6cbb\u7642\u6b74\u306e\u306a\u3044\u9032\u884c\u6027\u8ee2\u79fb\u6027NPC\u60a3\u8005\u306e\u7b2c\u4e00\u9078\u629e\u85ac\u3068\u3057\u3066\u3001\u30c8\u30ea\u30d1\u30ea\u30de\u30d6 (\u5316\u5b66\u7642\u6cd5\u3068\u306e\u4f75\u7528) \u306e\u8ffd\u52a0NDA\u3092\u7533\u8acb\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u7533\u8acb\u306f\u30012020\u5e749\u6708\u306b\u767a\u8868\u3055\u308c\u305f\u7b2c3\u76f8JUPITER-02\u81e8\u5e8a\u8a66\u9a13\u306e\u826f\u597d\u306a\u7d50\u679c\u306b\u57fa\u3065\u3044\u3066\u3044\u307e\u3059\u3002<\/p>\n<p><strong>ASCO\u3067\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\uff1a<\/strong>Junshi Biosciences\u306f\u3001\u7b2c3\u76f8JUPITER-02\u81e8\u5e8a\u8a66\u9a13\u306e\u7d50\u679c\u3092\u767a\u8868\u3057\u3001\u30c8\u30ea\u30d1\u30ea\u30de\u30d6\u3092\u30b2\u30e0\u30b7\u30bf\u30d3\u30f3\/\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\u3068\u4f75\u7528\u3057\u3066\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u6cbb\u7642\u3092\u884c\u3046\u3053\u3068\u3067\u3001\u30b2\u30e0\u30b7\u30bf\u30d3\u30f3\/\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\u5358\u72ec\u306b\u6bd4\u3079\u3066\u512a\u308c\u305fPFS\u3068\u5ba2\u89b3\u7684\u594f\u52b9\u7387 (ORR)\u3001\u304a\u3088\u3073\u9577\u3044DOR\u304c\u5f97\u3089\u308c\u3001\u7ba1\u7406\u53ef\u80fd\u306a\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u793a\u3059\u3053\u3068\u3092\u793a\u3057\u307e\u3057\u305f\u3002<\/p>\n<p><strong>\u4eca\u5f8c\u306e\u5c55\u671b\uff1a<\/strong>\u30c8\u30ea\u30d1\u30ea\u30de\u30d6\u306f\u3001\u3059\u3067\u306bNPC\u306e\u30bb\u30ab\u30f3\u30c9\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u304c\u3001\u4eca\u56de\u306e\u9069\u5fdc\u62e1\u5927\u306b\u3088\u308a\u3001\u30ab\u30e0\u30ec\u30ea\u30ba\u30de\u30d6 (AiRuiKa, 2021\u5e746\u6708\u627f\u8a8d) \u306b\u6b21\u30502\u3064\u76ee\u306ePD-1\u963b\u5bb3\u85ac\u3068\u3057\u3066\u3001\u4e2d\u56fd\u672c\u571f\u3067\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u304c\u9ad8\u304f\u3001\u5e02\u5834\u306e\u6f5c\u5728\u529b\u304c\u307b\u3068\u3093\u3069\u306a\u3044\u518d\u767a\u30fb\u8ee2\u79fb\u6027NPC\u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3068\u3057\u3066\u4f7f\u7528\u3055\u308c\u308b\u3053\u3068\u306b\u306a\u308a\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u30c8\u30ea\u30d1\u30ea\u30de\u30d6\u306f\u3001\u56fd\u5bb6\u511f\u9084\u85ac\u30ea\u30b9\u30c8\u306b\u542b\u307e\u308c\u3066\u3044\u308b\u306b\u3082\u304b\u304b\u308f\u3089\u305a\u3001camrelizumab\u3084\u3001\u30c6\u30a3\u30b9\u30ea\u30ba\u30de\u30d6 (Baizean) \u3084\u30b7\u30f3\u30c1\u30ea\u30de\u30d6 (Daboshu) \u306a\u3069\u3001NPC\u306e\u7b2c3\u76f8\u8a66\u9a13\u3067\u4eca\u5f8c\u767a\u58f2\u3055\u308c\u308bPD-1\u963b\u5bb3\u5264\u3068\u306e\u6fc0\u3057\u3044\u7af6\u4e89\u306b\u3055\u3089\u3055\u308c\u308b\u3053\u3068\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>\u3053\u308c\u3089\u306e\u7d50\u679c\u3068\u7d99\u7d9a\u7684\u306a\u9032\u5c55\u306f\u3001\u4e2d\u56fd\u672c\u571f\u306e\u56fd\u5185\u30e1\u30fc\u30ab\u30fc\u304c\u3001\u56fd\u5185\u306ePD-1\u963b\u5bb3\u5264\u5e02\u5834\u3092\u8d85\u3048\u3066\u3001\u4eca\u3084\u4e16\u754c\u7684\u306b\u3082\u5f71\u97ff\u529b\u3092\u5897\u3057\u3066\u3044\u308b\u3053\u3068\u3092\u8a3c\u660e\u3057\u3066\u3044\u307e\u3059\u3002NPC\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066FDA\u304b\u3089\u753b\u671f\u7684\u306a\u6307\u5b9a\u3092\u53d7\u3051\u305fTuoyi\u306f\u3001\u4e2d\u56fd\u672c\u571f\u3067\u958b\u767a\u3055\u308c\u305f\u6cbb\u7642\u85ac\u306e\u56fd\u969b\u7684\u306a\u98db\u8e8d\u3092\u8c61\u5fb4\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u306e\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8 Amardeep Singh, Akash Saini, Gang Wang, Shuxin Bao\u304c\u672c\u8a18\u4e8b\u306b\u5354\u529b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>\u305d\u306e\u4ed6\u306e\u304c\u3093\u6cbb\u7642\u306e\u30b2\u30fc\u30e0\u30c1\u30a7\u30f3\u30b8\u30e3\u30fc\u306b\u95a2\u3059\u308b\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u306e\u898b\u89e3\u306b\u3064\u3044\u3066\u306f\u3001<a href=\"https:\/\/clarivate.com\/blog\/tag\/asco2021\/\">ASCO 2021\u306e\u5206\u6790<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>&nbsp;<\/p>\n<p><strong>References<\/strong><\/p>\n<ol>\n<li><em>Efficacy and safety analysis of Chinese patients in monarchE: Abemaciclib combined with adjuvant endocrine therapy for high-risk HR+, HER2- early breast cancer. ASCO 2021. Abstract 522. <\/em><\/li>\n<li><em>Dalpiciclib versus placebo plus fulvestrant in HR+\/HER2- advanced breast cancer that relapsed or progressed on previous endocrine therapy (DAWNA-1): A multicenter, randomized, phase 3 study. ASCO 2021. Abstract 1002.<\/em><\/li>\n<li><em>Pyrotinib as neoadjuvant therapy for HER2+ breast cancer: A multicenter, randomized, controlled, phase II trial. ASCO 2021. Abstract 574<\/em><\/li>\n<li><em>Randomized phase III trial of aumolertinib (HS-10296, Au) versus gefitinib (G) as first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) and EGFR exon 19 del or L858R mutations (EGFRm). ASCO 2021. Abstract 9013. <\/em><\/li>\n<li><em>Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II\/III trial. ASCO 2021. Abstract 4506.<\/em><\/li>\n<li><em>JUPITER-02: Randomized, double-blind, phase III study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC). ASCO 2021. Abstract LBA2.<\/em><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>\u82f1\u8a9e\u539f\u6587\u30b5\u30a4\u30c8 \u672c\u8a18\u4e8b\u306f\u82f1\u6587\u30d6\u30ed\u30b0\u3092\u65e5\u672c\u8a9e\u306b\u7ffb\u8a33\u518d\u7de8\u96c6\uff08\u4e00\u90e8\u8ffd\u8a18\u3092\u542b\u3080\uff09\u3057\u305f\u3082\u306e\u3067\u3059\u3002\u672c\u8a18\u4e8b\u306e\u6b63\u5f0f\u8a00\u8a9e\u306f\u82f1\u8a9e\u3067\u3042\u308a\u3001\u305d\u306e\u5185\u5bb9\u30fb\u89e3\u91c8\u306b\u3064\u3044\u3066\u306f\u82f1\u8a9e\u304c\u512a\u5148\u3057\u307e\u3059\u3002 &nbsp; \u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u306e\u304c\u3093\u9818\u57df\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u306f\u3001\u4e2d\u56fd\u672c\u571f\u304b\u3089\u306eASCO 2021\u306e\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u3092\u5206\u6790\u3057\u3001\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u306e\u5c55\u671b\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u3068\u4e88\u60f3\u3055\u308c\u308b\u91cd\u8981\u306a\u30c8\u30ec\u30f3\u30c9\u3068\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u660e\u3089\u304b\u306b\u3057\u307e\u3057\u305f\u3002 &nbsp; 2021\u5e74\u306eASCO\u5e74\u6b21\u7dcf\u4f1a\u3067\u306f\u3001\u4e2d\u56fd\u672c\u571f\u306e\u4f01\u696d\u304c\u5f37\u304f\u6ce8\u76ee\u3055\u308c\u307e\u3057\u305f\u3002\u30c9\u30e9\u30c3\u30b0\u30e9\u30f3\u30c9\u30b9\u30b1\u30fc\u30d7\u306b\u5927\u304d\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u3053\u3068\u304c\u4e88\u60f3\u3055\u308c\u308b\u6cbb\u7642\u6cd5\u306b\u30b9\u30dd\u30c3\u30c8\u3092\u5f53\u3066\u305fDrugs to Watch\u2122\u30b7\u30ea\u30fc\u30ba\u306e\u4e00\u74b0\u3068\u3057\u3066\u3001\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u306eChina In-Depth\u2122\u306e\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u304c\u4e2d\u56fd\u672c\u571f\u304b\u3089\u306e200\u4ee5\u4e0a\u306e\u6284\u9332\u3092\u30ec\u30d3\u30e5\u30fc\u3057\u3001\u4ee5\u4e0b\u306e\u3088\u3046\u306a\u3044\u304f\u3064\u304b\u306e\u6ce8\u76ee\u3059\u3079\u304d\u30c8\u30ec\u30f3\u30c9\u3092\u78ba\u8a8d\u3057\u307e\u3057\u305f\u3002 \u4e2d\u56fd\u672c\u571f\u306e\u4f01\u696d\u306b\u3088\u308b\u53e3\u982d\u767a\u8868\u306e\u6570\u304c\u3001ASCO 2020\u3067\u306f11\u4ef6\u3060\u3063\u305f\u306e\u306b\u5bfe\u3057\u3001ASCO 2021\u3067\u306f20\u4ef6\u3068\u5927\u5e45\u306b\u5897\u52a0 \u56fa\u5f62\u304c\u3093\u3092\u5bfe\u8c61\u3068\u3057\u305f\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u91cd\u8981\u306a\u81e8\u5e8a\u8a66\u9a13\u3067\u3001\u6709\u671b\u306a\u7d50\u679c\u3092\u767a\u8868\u3059\u308b\u4e2d\u56fd\u4f01\u696d\u306e\u6570\u304c\u5897\u52a0 &nbsp; \u56f31\uff1aASCO\u306b\u304a\u3051\u308b\u4e2d\u56fd\u672c\u571f\u304b\u3089\u306e\u53e3\u982d\u767a\u8868\u306e\u6570 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; \u51fa\u5178: ASCO meeting library &nbsp; 1&#8230;.<\/p>\n","protected":false},"author":161,"featured_media":3451,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_links_to":"","_links_to_type":0,"footnotes":""},"categories":[1309,1297,1300,1228],"tags":[],"class_list":["post-3446","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biopharma","category-blog","category-cortellis","category-life-sciences-healthcare","clarivate-industry-life-sciences-and-healthcare","clarivate-product-biopharma"],"acf":[],"lang":"ja","translations":{"ja":3446},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/3446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/users\/161"}],"replies":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/comments?post=3446"}],"version-history":[{"count":0,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/3446\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=3446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/categories?post=3446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/tags?post=3446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}